CD3 Recombinant Rabbit Monoclonal Antibody (E9C3)
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0483721
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Contract amount
- Not on record
About this award
Life Technologies Corporation has been awarded a contract by the University of Virginia for the provision of CD3 Recombinant Rabbit Monoclonal Antibody (E9C3), effective September 24, 2026. The single line item procures monoclonal antibody products at a unit price of $489 per unit, with delivery to Ji Song. The contract is classified under Virginia state procurement.
The specific contract value, annual value, cumulative value, and detailed period of performance are not specified in the available documentation. Similarly, the exact county location and place of performance, beyond the University of Virginia as the contracting organization, cannot be determined from the materials provided. As a prime contractor award, Life Technologies Corporation maintains full contractual responsibility for fulfilling the antibody supply requirements under this procurement action.
Line items
| Item | Total |
|---|---|
| CD3 Recombinant Rabbit Monoclonal Antibody (E9C3) | — |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0483721?
Contract A207_PO-0483721 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on September 24, 2026.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award